DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Berger PB, Bhatt DL, Fuster V. , et al; CHARISMA Investigators.
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Circulation 2010;
121 (23) 2575-2583
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.